You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: April 7, 2020

DrugPatentWatch Database Preview

Litigation Details for Brigham Young University v. Pfizer (D. Utah 2006)

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Brigham Young University v. Pfizer (D. Utah 2006)

Docket   Start Trial Date Filed 2006-10-18
Court District Court, D. Utah Date Terminated 2012-06-13
Cause 28:1332 Diversity-Other Contract Assigned To Brian Theadore Stewart
Jury Demand Plaintiff Referred To Magistrate Judge Brooke C. Wel
Patents 5,466,823; 5,563,165; 5,633,272; 5,760,068
Attorneys Adam C. Anderson; Arthur B. Berger; Charles W. Douglas; David B Thomas; David R. Parkinson; George M. Haley; James S. Jardine; Keith C. Ricker; L. Richard Williams; Lee M. Andelin; Leo R. Beus; Lisa A. Schneider; Mark M. Bettilyon; Neil H. Wyland; Richard F. O'Malley , Jr; Rick B. Hoggard; Samuel C. Straight; Scot C. Stirling; Stephen M. Craig; Timothy J. Paris; Todd L. Krause; Victoria L. Romney
Firms Beus Gilbert Pllc; Grant Anderson LLC; Holme Roberts & Owen LLP (Ut); Sidley Austin LLP (Il); Sidley Austin LLP NY
Link to Docket External link to docket
Small Molecule Drugs cited in Brigham Young University v. Pfizer
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Brigham Young University v. Pfizer (D. Utah 2006)

Date Filed Document No. Description Snippet Link To Document
2006-12-13 30 Answer to Complaint ) (United States Patent Nos. 5,380,738; 5,393,790; 5,418,254; 5,420,343; 5,466,823; 5,476,944; 5,486,…United States Patent and Trademark Office ("PTO") would have issued any such patents to Dr. Simmons…University of Rochester were named on a patent (United States Patent Number 6,048,850) that related to cyclooxygenase…admit that U.S. Patent Number 5,420,343 dated May 30, 1995, and United States Patent Number 5,476,944…discoveries and inventions, whether or not patentable or patented shall be as follows." Defendants deny External link to document
2009-09-30 302 Order on Motion to Amend/Correct pending reissue patent application for U.S. Patent No. 5,760,068 (the "'068 patent"). In…from the present litigation to the United States Patent and Trademark Office ("PTO") with respect…provide highly confidential documents to Pfizer patent attorney, Phil Polster, so he may oversee the submission…confidential documents to Pfizer's in-house patent counsel, Phil Polster, so that he may submit the… receiving an agreement from our patent attorney which follows the guidelines and External link to document
2011-02-01 529 Response to Motion U.S. Patent No. 5,563,165, 8 Oct 96 PFC01567139-167 15. U.S. Patent No. 5,…after the issuance of a patent to negotiate a royalty agreement for that patent. Id. And as lawyer Swaney…Monsanto applied for its first patent on Celebrex, SOF ΒΆ 95, and that patent was issued two years later …Celebrex-related patent on 8 October 1996.24 Then on 27 May 1997, Monsanto received a patent on the drug …third Celebrex-related patent.26 Monsanto did not disclose any of these patents to BYU, nor did Monsanto External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.